dividends
NYSE · SRXH
SRx Health Solutions Inc.
Healthcare · Drug Manufacturers - General
$1.61
Up+$0.00 (+0.00%)
Updated Oct 4, 2026, 7:26 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12.92M
- P/E ratio
- -0.67
- Dividend yield
- 3.11%
- 52-week range
- $0.96 – $42.61
- Volume
- 475.49K
- Avg. volume
- 892.09K
Price performance · SRXH
SRXH price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
SRXH closed at $1.61 after 19 trading sessions, up 1.90% for the selected period.
- Last close
- $1.61
- Period change
- +1.90%
- Period low
- $1.51
- Period high
- $1.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $1.62 | $1.6401 | $1.58 | $1.61 | 475.49K |
| Oct 1, 2026 | $1.56 | $1.635 | $1.50 | $1.61 | 627.09K |
| Sep 30, 2026 | $1.58 | $1.60 | $1.55 | $1.55 | 247.12K |
| Sep 29, 2026 | $1.69 | $1.69 | $1.58 | $1.60 | 401.13K |
| Sep 28, 2026 | $1.68 | $1.68 | $1.575 | $1.58 | 514.03K |
| Sep 25, 2026 | $1.73 | $1.79 | $1.675 | $1.70 | 1.06M |
| Sep 24, 2026 | $1.70 | $1.7901 | $1.6924 | $1.73 | 758.6K |
| Sep 23, 2026 | $1.77 | $1.82 | $1.68 | $1.70 | 880.46K |
| Sep 22, 2026 | $1.74 | $1.83 | $1.68 | $1.78 | 921.28K |
| Sep 21, 2026 | $1.72 | $1.85 | $1.66 | $1.72 | 1.16M |
| Sep 18, 2026 | $1.64 | $1.79 | $1.64 | $1.67 | 1.15M |
| Sep 17, 2026 | $1.63 | $1.6584 | $1.57 | $1.62 | 365.53K |
| Sep 16, 2026 | $1.70 | $1.72 | $1.57 | $1.60 | 469.35K |
| Sep 15, 2026 | $1.65 | $1.72 | $1.6266 | $1.71 | 438.68K |
| Sep 14, 2026 | $1.58 | $1.6993 | $1.56 | $1.68 | 881.22K |
| Sep 11, 2026 | $1.58 | $1.665 | $1.55 | $1.59 | 571.27K |
| Sep 10, 2026 | $1.48 | $1.64 | $1.47 | $1.56 | 989.48K |
| Sep 9, 2026 | $1.56 | $1.60 | $1.51 | $1.51 | 452.37K |
| Sep 8, 2026 | $1.51 | $1.60 | $1.51 | $1.58 | 358.13K |
Latest SRXH news
The latest Smart Investors Daily articles mentioning SRXH.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…